Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

• Main Authors: Sarin, S.K, Kumar, M, Lau, G.K
• Other Authors: MEDICINE
• Format: Editorial
• Published: 2020
• Subjects: adefovir dipivoxil; alanine aminotransferase; clevudine; cyclopentane derivative; entecavir; hepatitis B(e) antigen; lamivudine; peginterferon alpha; RNA directed DNA polymerase inhibitor; telbivudine; tenofovir alafenamide; tenofovir disoproxil; virus vaccine; antivirus agent; adaptive immunity; age distribution; alanine aminotransferase blood level; Asian; chronic hepatitis B; clinical practice; combination chemotherapy; controlled clinical trial (topic); cryoglobulinemia; disease association; disease exacerbation; drug choice; Editorial; geographic distribution; glomerulonephritis; Guillain Barre syndrome; hepatitis B; human; Human immunodeficiency virus infection; immunological tolerance; immunoreactivity; incidence; infection prevention; infection risk; innate immunity; kidney failure; liver disease; liver stiffness; liver transplantation; medical history; medical terminology; mixed infection; monotherapy; multicenter study (topic); nonhuman; patient assessment; patient counseling; personal experience; polyarteritis nodosa; practice guideline; predictive value; pregnancy; prevalence; priority journal; public health; public health problem; publication; risk assessment; screening; seroconversion; serum sickness; time to treatment; treatment duration; treatment indication; vaccination; vertical transmission; viral clearance; virus load; virus pathogenesis; virus reactivation; virus transmission; acute disease; Africa; Asia; disease management; female; Hepatitis B virus; Hepatitis B, Chronic; isolation and purification; male; Acute Disease; Antiviral Agents; Disease Management; Female; Hepatitis B; Humans; Male
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/179965
• Institution: National University of Singapore

10.1007/s12072-015-9675-4